NCT02366390

Brief Summary

The purpose of this trial is to determine whether a minimal homebased psychoeducative intervention is effective in management of anxiety and dyspnea in patients with severe chronic obstructive pulmonary disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for phase_4 chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Feb 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

February 6, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 19, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

June 23, 2016

Status Verified

October 1, 2015

Enrollment Period

1.2 years

First QC Date

February 6, 2015

Last Update Submit

June 22, 2016

Conditions

Keywords

PsychoeducativeHADSCOPDdyspnea

Outcome Measures

Primary Outcomes (1)

  • Change in HADS-A score from baseline to three months follow-up

    The Hospital Anxiety and Depression Scale (HADS), subscale for anxiety HADS-A is a self-completed questionnaire that measure symptoms of general anxiety

    Three months

Secondary Outcomes (5)

  • Change in CRQ score from baseline to three months follow-up

    Three months

  • Change in SGRQ score from baseline to three months follow-up

    Three months

  • Change in HADS-D score from baseline to three months follow-up

    Three months

  • Number of admissions

    Three months

  • Length of Stay (LOS)

    Three months

Study Arms (2)

Psychoeducative intervention

EXPERIMENTAL

A psychoeducative dialogue and one telephone booster session

Behavioral: Psychoeducative intervention

Usual care

NO INTERVENTION

Usual care according to current guidelines.

Interventions

Patient-education about feelings, cognitions, behaviors and bodily sensations related to management of dyspnea and associated anxiety

Psychoeducative intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a confirmed diagnosis of COPD and classified as category C or D according to the Global initiative for Obstructive Lung Disease (GOLD), and who have a HADS - anxiety subscale score ≥ 8 and are willing to participate and able to provide written informed consent

You may not qualify if:

  • Patients with a psychiatric diagnosis or pulmonary cancer or patients who are involved in any other interventional clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nordsjællands Hospital, Department of Pulmonary & Infectious Diseases

Hillerød, Capital Region of Denmark, 3400, Denmark

Location

Related Publications (1)

  • Bove DG, Overgaard D, Lomborg K, Lindhardt BO, Midtgaard J. Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol. BMJ Open. 2015 Jul 7;5(7):e008031. doi: 10.1136/bmjopen-2015-008031.

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveAnxiety DisordersDyspnea

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMental DisordersRespiration DisordersSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Julie Midtgaard, PHD

    The University Hospital Centre for Health Research, Copenhagen University Hospital, Rigshospitalet

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2015

First Posted

February 19, 2015

Study Start

February 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

June 23, 2016

Record last verified: 2015-10

Locations